1ROBERT S, TRICINO G, LANZAROTCI A, et al, Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population [J]. Circultion, 2001, 104 : 1385 - 1392.
2McKAY D W, MYERS M G, t3OLLI P. A Chockalingam. Masked hypertension: A common but insidious presentation of hypertension[J]. Can J Cardiol, 2006,22:617-620.
3SEGA R, TROCINO G, LANZAROTTI A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study ) [J]. Circulation, 2001,104 : 1385-1392.
4BOBRIE G, CHATELLIER G, GENES N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients[J]. JAMA, 2004,291 : 1342-1349.
5GRASSI G, TURRI C, VAILATI S, et al. Muscle and skin sympathetic nerve traffic during the "whitecoat effect"[J]. Circulation, 1999,100 : 222- 225.
6WING L M, BROWN M A, BEIIAN L J, et al. "Reverse white-coat hypertension" in older hypertension [J]. J Hypertens, 2002,20 : 639-644.
8MANCIA G, SEGA R, BRAVI C, et al. Ambulatory blood pressure normality: results from the PAMELA study[J]. J Hypertens, 1995,13 : 1377-1390.
9OHKUBO T, KIKUYA M, METOKI H, et al. Prognosis of "masked hypertension" and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study[J]. J Am Coll Cardiol, 2005,46: L508-515.
10LIU J E, ROMAN M J, PINI R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure [J]. Ann Inter Med, 1999,131:564-572.
二级参考文献11
1Perloff D, Sokolow M, Cowan RM, et al. Prognostic value of ambulatory blood pressure measurements; further analyses[J]. J Hypertens, 1989,7(Suppl) :S3 - S10.
2Devereux RB, Picketing TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension:importance of blood pressure response to regularly recurring stress[J]. Circulation,1983.68:470- 476.
3Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension[J]. Hypertens, 1994,24:793 - 801.
4Pickering TG. Utility of 24-hour ambulatory blood pressure monitoring in clinical practice[J]. Can J Cardiol, 1995,11:43H- 48H.
5Staessen J, Fazgard R, Lijinen P, et al.Ambulatory blood pressure monitoring in dinical trials[J]. J Hypertens,1991,9 (Suppl 1):S13-S19.
6Staessen J, Fargard R, lijinen P, et al. Reference values for ambulatory blood pressure: a meta-analysis[ J ]. J Hypertens, 1990,8(Suppl 6) :S57- S64.
7Enstrom I, Thulin T, Lindholm L, et al. How good are standardized blood pressure reoordings for diagnosing hypertension? A comparison between office and ambulatory blood pressure[J ]. J Hypertens, 1991,9:561 - 566.
8Goldman, Arlhar G. Elevated ambulatory blood pressure and normal office blood pressure[J] .Ann Intern Med ,2000,132(10) :842.
9Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with devated ambulatory and normal office blood pressure[J]. Ann Intern Med. 1999,131:564 - 572.
10Picketing TG, Davidson KW, Rafey M, et al. Masked hypertension: are those with normal office but elevated ambulatory blood pressure at risk? 12^th European meeting on hyperetnsion [C], 2002, Prague, S176.
1MANCIA G, DE BACKER G, DOMINICZAK A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension[J]. J Hypertens,2007,25 : 1751--1762.
2VERDECCHIA P, ANGELI F, GATTOBIGIO R,et al. The clinical significance of white-coat and masked hypertension[J]. Blood Press Monit, 2007,12 : 387- 389.
3STRANDBERG T E, SALOMAA V. White coat effect,blood pressure and mortality in men. prospective cohort study[J]. Eur Heart J,2000,21:1714- 1718.
4SMITH P A. GRAHAM L N,MACKINTOSH A F, et al. Sympathetic neural mechanisms in white-coate hypertension[J]. J AM Coll Cardiol, 2002,40 : 126-- 132.
5CARDILLO C,DEFELICE F, CAMPIA U, et al. Psychophysiological reactivity and cardiac end organ changes in whit coat hypertension [J]. Hypertension, 1993,21 : 836 -- 844.
6MULDOON M F, NAZZARO P, SUTTON-TYRRELL K, et al. White coat hypertension and carotid artery atherosclerosis : A matching study[J]. Arch Intern Med, 2000,160 : 15()7-- 1512.
7MAKRIS T, STAVROULAKIS G, PAPADOPOU- LOS D, et al. White coat hypertension and haemostatic/fibrinolytic balance disorders [J]. Eur Cytokine Netw,2006 ,17:137--141.
8BJORKLUND K, LIND L,VESSBY B,et al. Different metabolic predictors of white coat and sustained hypertension over20year follow up period: a population based study of elderly men [J]. Circulation , 2002,106..63--68.
9GoMEZ-CEREZO J, RIOS BLANCO J J, SUAREZ GARCIA I, et al. Noninvasive study of endothelial function in white coat hypertension [J]. Hypertension, 2002 ,40:304--309.
10PIERDOMENICO S D, CIPOLLONE F, LAPENNA D,et al. Endothelial function in sustained and white coat hypertension[J]. Am J Hypertens, 2002 , 15 : 946--952.
